Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  133 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Subject : acute kidney injury
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.

  • Authors : Shi Y; Department of Pharmacy, Peking University Third Hospital, No.49 Huayuan North Road, Haidian District, Beijing, 100191, China.; Department of Pharmacy, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei Province, China.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/epidemiology

  • Source: Acta diabetologica [Acta Diabetol] 2024 Jun; Vol. 61 (6), pp. 755-764. Date of Electronic Publication: 2024 Mar 05.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis.

  • Authors : Wang T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Ji D

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5876.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Read More Add to Saved list
×
Academic Journal

A cohort study of sodium-glucose cotransporter-2 inhibitors after acute kidney injury among Veterans with diabetic kidney disease.

  • Authors : Murphy DP; Department of Medicine, Medical School, University of Minnesota, Minneapolis, Minnesota, USA. Electronic address: .; Wolfson J

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/mortality

  • Source: Kidney international [Kidney Int] 2024 Jul; Vol. 106 (1), pp. 126-135. Date of Electronic Publication: 2024 Apr 27.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Effects of Dapagliflozin on contrast-induced acute kidney injury in patients with type 2 diabetes mellitus underwent percutaneous coronary intervention].

  • Authors : Yang SC; Department of Cardiology, Tianjin University Chest Hospital, Tianjin 300222, China.; Ma YF

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Diabetes Mellitus, Type 2* ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2024 Jun 11; Vol. 104 (22), pp. 2059-2065.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

Targeting Nrf2/HO-1 and NF-κB/TNF-α signaling pathways with empagliflozin protects against atrial fibrillation-induced acute kidney injury in rats.

  • Authors : Badreldin H; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Egypt. Electronic address: .; El-Karef A

Subjects: Glucosides*/Glucosides*/Glucosides*/pharmacology ; Glucosides*/Glucosides*/Glucosides*/therapeutic use ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/metabolism

  • Source: Toxicology [Toxicology] 2024 Aug; Vol. 506, pp. 153879. Date of Electronic Publication: 2024 Jul 04.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0361055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3185

Record details

Read More Add to Saved list
×
Academic Journal

Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review.

  • Authors : Ziser KED; Centre for Medication Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.; Pharmacy Department, Princess Alexandra Hospital, Brisbane, QLD, Australia.

Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/epidemiology ; Heart Failure*/Heart Failure*/Heart Failure*/epidemiology

  • Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Jul; Vol. 90 (7), pp. 1541-1558. Date of Electronic Publication: 2024 May 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identification of risk factors associated with acute kidney injury in patients taking sodium-glucose cotransporter-2 inhibitors.

  • Authors : Schumacher C; Department of Pharmacy Practice, Midwestern University College of Pharmacy, Downers Grove Campus, Downers Grove, Illinois, USA.; Pharmacy, Chronic Disease Management, Advocate Health, Chicago, Illinois, USA.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Diabetes Mellitus, Type 2* ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced

  • Source: Pharmacotherapy [Pharmacotherapy] 2024 Mar; Vol. 44 (3), pp. 249-257. Date of Electronic Publication: 2024 Jan 12.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Liver, renal, genitourinary and diabetic ketoacidosis risks among new users of empagliflozin versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Post-authorization safety study based on multinational cohorts.

Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/epidemiology ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/complications

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Apr; Vol. 26 (4), pp. 1291-1304. Date of Electronic Publication: 2024 Jan 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Association of SGLT2 inhibitor dapagliflozin with risks of acute kidney injury and all-cause mortality in acute myocardial infarction patients.

  • Authors : Cai D; Department of Cardiology, the Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, Jiangsu, 213000, China.; Dalian Medical University, Dalian, Liaoning, 116000, China.

Subjects: Sodium-Glucose Transporter 2 Inhibitors* ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Myocardial Infarction*

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Apr; Vol. 80 (4), pp. 613-620. Date of Electronic Publication: 2024 Feb 06.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041

Record details

Read More Add to Saved list
×
Academic Journal

What Are the Impacts of Introducing an SGLT2 Inhibitor after a Recent Episode of Acute Kidney Injury?

  • Authors : Proença de Moraes T; Postgraduate Program in Health and Biological Sciences-Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.

Subjects: Acute Kidney Injury* ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Kidney360 [Kidney360] 2024 Mar 01; Vol. 5 (3), pp. 333-334.Publisher: Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 101766381 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  133 results for ""Sodium-Glucose Transporter 2 Inhibitors""